Luis Manso Selected Research

Luis Manso Research Topics

Disease

34	Breast Neoplasms (Breast Cancer) 05/2024 - 09/2013
19	Neoplasms (Cancer) 12/2023 - 09/2006
10	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 01/2018
5	Triple Negative Breast Neoplasms 04/2023 - 11/2015
4	Neoplasm Metastasis (Metastasis) 05/2024 - 11/2014
3	Disease Progression 12/2023 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2023 - 01/2021
2	Adenocarcinoma 12/2023 - 01/2021
2	Carcinoma (Carcinomatosis) 10/2023 - 01/2018
2	Asthenia 01/2023 - 01/2019
2	Fatigue 01/2023 - 03/2017
2	Leukopenia 01/2019 - 11/2017
2	Neutropenia 01/2019 - 11/2017
2	Asthma (Bronchial Asthma) 06/2011 - 05/2011
1	Adenosquamous Carcinoma 12/2023
1	Arthralgia (Joint Pain) 12/2023
1	Exanthema (Rash) 12/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023
1	Fever (Fevers) 12/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023
1	Stomach Neoplasms (Stomach Cancer) 10/2023
1	Endometrial Neoplasms (Endometrial Cancer) 10/2023
1	Ovarian Epithelial Carcinoma 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Genomic Instability 01/2023
1	Circulating Neoplastic Cells 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Fallopian Tube Neoplasms 02/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Febrile Neutropenia 01/2019
1	Alopecia (Baldness) 01/2019
1	Diarrhea 11/2017

Drug/Important Bio-Agent (IBA)

12	Hormones (Hormone)IBA 10/2023 - 09/2013
9	Bevacizumab (Avastin)FDA Link 12/2023 - 01/2018
8	PlatinumIBA 12/2023 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2019
5	olaparibIBA 12/2023 - 02/2019
5	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 11/2015
5	Phenobarbital (Luminal)FDA Link 12/2021 - 09/2013
5	ErbB Receptors (EGF Receptor)IBA 04/2021 - 10/2014
5	Trastuzumab (Herceptin)FDA Link 11/2020 - 01/2014
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2023 - 11/2020
4	human ERBB2 proteinIBA 01/2019 - 10/2014
3	Aromatase InhibitorsIBA 05/2024 - 06/2014
3	Everolimus FDA Link 05/2024 - 09/2013
3	eribulin FDA Link 10/2021 - 01/2018
3	Fulvestrant (Faslodex)FDA Link 04/2021 - 06/2014
3	abemaciclibIBA 04/2021 - 11/2017
3	palbociclibIBA 12/2020 - 11/2020
3	Estrogen ReceptorsIBA 03/2017 - 06/2014
2	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 09/2006
2	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 11/2015
2	Immune Checkpoint InhibitorsIBA 10/2023 - 11/2020
2	rucaparibIBA 08/2023 - 11/2022
2	niraparibIBA 01/2023 - 10/2021
2	Gemcitabine FDA Link 10/2021 - 11/2015
2	Anastrozole (Arimidex)FDA LinkGeneric 04/2021 - 06/2014
2	AnthracyclinesIBA 11/2020 - 01/2019
2	Lapatinib (GW572016)FDA Link 01/2020 - 10/2014
2	Phosphotransferases (Kinase)IBA 01/2018 - 03/2017
2	nintedanibIBA 03/2017 - 03/2017
1	atezolizumabIBA 12/2023
1	Immunoconjugates (Immunoconjugate)IBA 10/2023
1	Epidermal Growth Factor (EGF)IBA 10/2023
1	trastuzumab deruxtecanIBA 10/2023
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 04/2023
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 04/2023
1	Angiogenesis InhibitorsIBA 01/2023
1	tetrachloroisophthalonitrile (Bravo)IBA 10/2021
1	Capecitabine (Xeloda)FDA Link 10/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2021
1	Letrozole (Femara)FDA LinkGeneric 04/2021
1	tisotumab vedotinIBA 01/2021
1	durvalumabIBA 11/2020
1	ribociclibIBA 11/2020
1	taxaneIBA 11/2020
1	ME-344IBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 11/2019
1	SolventsIBA 11/2019
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 11/2019
1	1-dodecylpyridoxal (PLD)IBA 02/2019
1	polyadenosineIBA 02/2019
1	Diphosphates (Pyrophosphates)IBA 02/2019
1	Ribose (D-Ribose)IBA 02/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2019
1	liposomal doxorubicin (Doxil)FDA Link 02/2019
1	Taxoids (Taxanes)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	TransferasesIBA 01/2019
1	Ado-Trastuzumab EmtansineIBA 08/2018
1	balixafortideIBA 01/2018
1	Cyclin-Dependent Kinase 4IBA 11/2017

Therapy/Procedure

29	Therapeutics 05/2024 - 09/2013
13	Drug Therapy (Chemotherapy) 05/2024 - 03/2017
3	Neoadjuvant Therapy 08/2023 - 11/2015
2	Drug Tapering 01/2023 - 01/2017
1	Cytoreduction Surgical Procedures 08/2023
1	Oncolytic Virotherapy 05/2022
1	Immunotherapy 05/2022
1	Adjuvant Chemotherapy 10/2021